Dialectic Therapeutics is a biotechnology company focused on creating innovative new technologies to end cancer.
Dialectic Therapeutics has raised $14.4M in total funding. The most recent round was Grant. The last funding was announced in August 2021.
Dialectic Therapeutics's investors include Cancer Prevention and Research Institute of Texas.
Dialectic Therapeutics is headquartered in Dallas, United States.
Dialectic Therapeutics is a biotechnology company focused on creating innovative new technologies to end cancer.
Dialectic Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dialectic Therapeutics — Funding & Investors." VCBacked, August 20, 2021, https://www.vcbacked.co/company/dialectic-therapeutics. Accessed September 30, 2026.
VCBacked. (2021). Dialectic Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/dialectic-therapeutics
{{cite web |title=Dialectic Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dialectic-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated